Zelnorm recall leads to lawsuits for some users
It has been one month since the Zelnorm recall was announced after the FDA determined that the IBS medication could increase the risk of cardiovascular events for users. The lawyers at Saiontz & Kirk, P.A. have been contacted by hundreds of people concerned about injuries caused by the medication, and Zelnorm lawsuits are being reviewed nationwide for those who suffered a heart attack, stroke or ischemic colitis while taking the medication, or within one year of stopping the drug.
>>INFORMATION: Zelnorm recall lawsuits
Zelnorm was prescribed for treatment of irritable bowel syndrome (IBS) where constipation was the primary symptom. The FDA requested that the IBS drug be withdrawn on March 30 after a review of data involving 18,000 patients demonstrated it could increase the risk of heart attacks, strokes and angina. The recall of Zelnorm now extends to Canada and Australia, as well as the United States.
The side effects of Zelnorm are especially troubling since most users were younger and otherwise healthy individuals. In addition, the drug has been shown to be an ineffective treatment for most constipation sufferers. The FDA felt that a Zelnorm recall was appropriate since the risk of serious injury or death outweighs the limited benefits the drug provided for treatment of non-life-threatening IBS.
ZELNORM LAWYERS
If you, a friend or family member believe injuries may have been caused by Zelnorm, request a free claim evaluation.
